| Net Cash Provided by (Used in) Operating Activities |
$19,132,000 |
USD |
-49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$146,277,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$7,548,000 |
USD |
-98% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
302,500,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
78,318,722 |
shares |
-3.3% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$172,957,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$88,267,000 |
USD |
-54% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$42,188,000 |
USD |
-22% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Depreciation |
$7,700,000 |
USD |
28% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$60,319,000 |
USD |
-19% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$1,740,585,000 |
USD |
0.54% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$259,253,000 |
USD |
24% |
Q1 2024 |
Q1 2024 |